Vascular Biogenics (NASDAQ:VBLT) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ VBLT opened at $0.24 on Friday. Vascular Biogenics has a 12 month low of $0.10 and a 12 month high […]

Related Keywords

Israel ,United States , ,Medicard Ltd ,Advisor Group Holdings Inc ,Vascular Biogenics Ltd ,Vascular Biogenics Company Profile ,Renaissance Technologies ,Envestnet Asset Management Inc ,Vascular Biogenics ,Free Report ,Get Free Report ,Sigma Investments ,Asset Management ,Advisor Group Holdings ,Group Holdings ,Biogenics Ltd ,Vascular Biogenics Daily ,Nasdaq Vblt ,Vblt ,Medical ,Initiated Coverage ,Stocknews Com ,